Rodgers Brothers’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.47M | Sell |
80,789
-50
| -0.1% | -$4.12K | 0.75% | 33 |
|
|
2025
Q4 | $6.89M | Buy |
80,839
+250
| +0.3% | +$20.5K | 0.82% | 31 |
|
|
2025
Q3 | $6.27M | Hold |
80,589
| – | – | 0.77% | 37 |
|
|
2025
Q2 | $6.3M | Sell |
80,589
-250
| -0.3% | -$18.6K | 0.8% | 34 |
|
|
2025
Q1 | $5.86M | Sell |
80,839
-500
| -0.6% | -$35.8K | 0.78% | 35 |
|
|
2024
Q4 | $6.02M | Hold |
81,339
| – | – | 0.79% | 34 |
|
|
2024
Q3 | $5.37M | Buy |
81,339
+1,045
| +1% | +$75.9K | 0.68% | 41 |
|
|
2024
Q2 | $7.42M | Sell |
80,294
-60
| -0.1% | -$5.31K | 1% | 26 |
|
|
2024
Q1 | $7.68M | Hold |
80,354
| – | – | 1.05% | 24 |
|
|
2023
Q4 | $6.13M | Buy |
80,354
+3,275
| +4% | +$228K | 0.97% | 28 |
|
|
2023
Q3 | $5.34M | Buy |
77,079
+5,750
| +8% | +$462K | 0.91% | 32 |
|
|
2023
Q2 | $6.73M | Buy |
71,329
+2,074
| +3% | +$180K | 1.18% | 20 |
|
|
2023
Q1 | $5.73M | Sell |
69,255
-1,500
| -2% | -$118K | 1.1% | 25 |
|
|
2022
Q4 | $5.28M | Sell |
70,755
-3,953
| -5% | -$305K | 1.06% | 25 |
|
|
2022
Q3 | $6.17M | Sell |
74,708
-250
| -0.3% | -$24.1K | 1.32% | 19 |
|
|
2022
Q2 | $7.13M | Sell |
74,958
-123
| -0.2% | -$12.7K | 1.41% | 18 |
|
|
2022
Q1 | $8.84M | Sell |
75,081
-1,625
| -2% | -$182K | 1.59% | 15 |
|
|
2021
Q4 | $9.94M | Sell |
76,706
-226
| -0.3% | -$26.4K | 1.77% | 11 |
|
|
2021
Q3 | $8.71M | Sell |
76,932
-200
| -0.3% | -$22.8K | 1.74% | 14 |
|
|
2021
Q2 | $7.99M | Sell |
77,132
-50
| -0.1% | -$4.71K | 1.53% | 16 |
|
|
2021
Q1 | $6.46M | Buy |
77,182
+1,500
| +2% | +$127K | 1.34% | 21 |
|
|
2020
Q4 | $6.9M | Sell |
75,682
-955
| -1% | -$79.2K | 1.58% | 17 |
|
|
2020
Q3 | $6.12M | Sell |
76,637
-7,300
| -9% | -$570K | 1.58% | 17 |
|
|
2020
Q2 | $5.8M | Sell |
83,937
-675
| -0.8% | -$48K | 1.57% | 17 |
|
|
2020
Q1 | $5.32M | Sell |
84,612
-495
| -0.6% | -$35.7K | 1.69% | 17 |
|
|
2019
Q4 | $6.62M | Sell |
85,107
-1,683
| -2% | -$131K | 1.72% | 17 |
|
|
2019
Q3 | $6.36M | Sell |
86,790
-450
| -0.5% | -$31.6K | 1.76% | 14 |
|
|
2019
Q2 | $5.37M | Sell |
87,240
-300
| -0.3% | -$18.1K | 1.49% | 20 |
|
|
2019
Q1 | $5.58M | Sell |
87,540
-3,150
| -3% | -$180K | 1.59% | 15 |
|
|
2018
Q4 | $4.63M | Sell |
90,690
-1,485
| -2% | -$75.1K | 1.49% | 14 |
|
|
2018
Q3 | $5.35M | Sell |
92,175
-6,000
| -6% | -$293K | 1.54% | 16 |
|
|
2018
Q2 | $4.76M | Hold |
98,175
| – | – | 1.45% | 17 |
|
|
2018
Q1 | $4.57M | Sell |
98,175
-4,575
| -4% | -$199K | 1.49% | 17 |
|
|
2017
Q4 | $3.86M | Hold |
102,750
| – | – | 1.26% | 27 |
|
|
2017
Q3 | $3.74M | Buy |
102,750
+1,500
| +1% | +$57.2K | 1.32% | 21 |
|
|
2017
Q2 | $3.99M | Hold |
101,250
| – | – | 1.47% | 18 |
|
|
2017
Q1 | $3.17M | Sell |
101,250
-600
| -0.6% | -$18.8K | 1.2% | 25 |
|
|
2016
Q4 | $3.18M | Sell |
101,850
-1,500
| -1% | -$48.6K | 1.25% | 24 |
|
|
2016
Q3 | $4.15M | Hold |
103,350
| – | – | 1.67% | 16 |
|
|
2016
Q2 | $3.44M | Sell |
103,350
-150
| -0.1% | -$5.13K | 1.41% | 23 |
|
|
2016
Q1 | $3.04M | Hold |
103,500
| – | – | 1.32% | 24 |
|
|
2015
Q4 | $2.73M | Hold |
103,500
| – | – | 1.27% | 25 |
|
|
2015
Q3 | $2.45M | Sell |
103,500
-4,158
| -4% | -$100K | 1.23% | 25 |
|
|
2015
Q2 | $2.56M | Sell |
107,658
-5,400
| -5% | -$122K | 1.21% | 25 |
|
|
2015
Q1 | $2.68M | Sell |
113,058
-1,500
| -1% | -$33.7K | 1.31% | 24 |
|
|
2014
Q4 | $2.43M | Sell |
114,558
-6,942
| -6% | -$139K | 1.21% | 26 |
|
|
2014
Q3 | $2.07M | Sell |
121,500
-7,800
| -6% | -$123K | 1.08% | 30 |
|
|
2014
Q2 | $1.85M | Sell |
129,300
-6,600
| -5% | -$89.5K | 0.92% | 37 |
|
|
2014
Q1 | $1.68M | Hold |
135,900
| – | – | 0.81% | 40 |
|
|
2013
Q4 | $1.49M | Buy |
135,900
+44,100
| +48% | +$497K | 0.74% | 41 |
|
|
2013
Q3 | $1.06M | Buy |
91,800
+7,200
| +9% | +$84.2K | 0.58% | 46 |
|
|
2013
Q2 | $948K | Buy |
+84,600
| New | +$1M | 0.57% | 48 |
|
Other funds holding EW
VCM
VPM
Rodgers Brothers's EW Position: Q1 2026 in Review
Rodgers Brothers reduced its Edwards Lifesciences (EW) stake by 0.06% in Q1 2026, selling an estimated $4.12K and leaving 80,789 shares worth $6.47M. The position accounts for 0.75% of the portfolio, ranked #33.
Rodgers Brothers first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.94M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Rodgers Brothers held 80,789 shares of Edwards Lifesciences worth $6.47M as of Q1 2026.
- Rodgers Brothers sold 50 Edwards Lifesciences shares in Q1 2026, an estimated $4.12K.
- Edwards Lifesciences made up 0.75% of Rodgers Brothers's portfolio in Q1 2026, its #33 holding.
- Rodgers Brothers first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Rodgers Brothers's Edwards Lifesciences position peaked at $9.94M in Q4 2021.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.